Propaq MD
by Zoll Medical Corporation, World Wide Headquarters
510(k) K112761
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK112761 | Date25 Apr 2012 | StatusActive |
Recalls
-
- Terminated Z-1311-2014
Defibrillator/Pacemaker/Monitor May Latch in a Continuous Device Reset Loop and cannot be used
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Zoll Propaq Md
- 510(k) Number
- FDA Product Code
- MKJ
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.5310
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Propaq MD is an Automated External Defibrillator (Non-Wearable), designed to deliver defibrillation therapy and non-invasive pacing while providing continuous patient monitoring. It integrates advanced cardiac monitoring with therapeutic interventions, including shock delivery and pacing, to support resuscitation efforts in critical care settings.
This device is intended for use in pre-hospital and transport environments, such as military and air medical operations. Supplied as a reusable medical device, it requires proper training for operation and adherence to regulatory guidelines. The Propaq MD holds FDA 510(k) clearance under the classification of Class III, with a registration number of 1218058 and other associated identifiers. It is not single-use and must be maintained according to manufacturer instructions.
Other devices from Zoll Medical Corporation, World Wide Headquarters
See all devices from Zoll Medical Corporation, World Wide Headquarters →
Questions
AI-generated answers, 18 Sep 2026
What types of environments is the ZOLL Propaq MD intended for use in, and why is this important for my application?
The ZOLL Propaq MD is specifically designed for pre-hospital and transport settings, including military and air medical operations. This distinction is important because it ensures the device meets the rigorous demands of mobile, high-stress environments where immediate cardiac intervention is critical. Its portability and advanced features—such as defibrillation, non-invasive pacing, and continuous monitoring—are optimized for scenarios where traditional hospital-based equipment may not be accessible.
Is the ZOLL Propaq MD a single-use device, or can it be reused? What does this mean for maintenance and cost?
The ZOLL Propaq MD is not single-use—it is classified as a reusable medical device. This means it requires regular maintenance, calibration, and cleaning according to the manufacturer’s instructions to ensure reliability and safety. While this avoids the cost of disposable units, it introduces ongoing operational expenses for servicing and training staff to handle the device properly.
What training or certification is required to operate the ZOLL Propaq MD effectively?
The device requires proper training for operation, as stated in the manufacturer’s guidelines. This is critical because it combines advanced therapeutic functions (shock delivery and pacing) with continuous monitoring, demanding proficiency to avoid misapplication or delays in emergency care. Training ensures operators can interpret readings and respond appropriately in critical situations.
How is the ZOLL Propaq MD’s regulatory status relevant to my procurement or clinical use?
The device holds FDA 510(k) clearance under Class III, meaning it has undergone rigorous review by the U.S. Food and Drug Administration to demonstrate safety and effectiveness for its intended use. This classification is important because it signals compliance with stringent regulatory standards, though it does not imply approval for specific clinical indications—only that the device meets FDA requirements for its designated purpose in pre-hospital and transport settings.